BIOWKS logo

Bio-Works Technologies AB (publ) Stock Price

NGM:BIOWKS Community·SEK 333.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BIOWKS Share Price Performance

SEK 3.33
1.33 (66.50%)
SEK 3.33
1.33 (66.50%)
Price SEK 3.33

BIOWKS Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
1 Reward

Bio-Works Technologies AB (publ) Key Details

SEK 82.8m

Revenue

SEK 20.7m

Cost of Revenue

SEK 62.1m

Gross Profit

SEK 64.7m

Other Expenses

-SEK 2.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.026
75.00%
-3.13%
0%
View Full Analysis

About BIOWKS

Founded
2006
Employees
33
CEO
Lone Carlbom
WebsiteView website
www.bio-works.com

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins. Its products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Recent BIOWKS News & Updates

Analysis Article Jul 15

Companies Like Bio-Works Technologies (NGM:BIOWKS) Can Afford To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Recent updates

No updates